| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Moiz Rehmanjee
DFI | Director of Finance/CFO | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 26/10/2017 | |
| Director/Board Member | - | 30/09/2016 | |
Moiz Rehmanjee
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 24.88M | |
| -0.52% | +3.21% | +89.52% | +125.32% | 1,057B | |
| +0.88% | +1.13% | +49.56% | +49.79% | 625B | |
| +0.89% | -1.95% | +24.23% | +63.19% | 435B | |
| +0.71% | +3.87% | +49.07% | +38.29% | 363B | |
| +0.64% | -0.49% | +33.94% | +38.94% | 296B | |
| +0.39% | -5.83% | +8.92% | +6.39% | 249B | |
| +1.51% | +6.69% | +42.58% | +58.47% | 222B | |
| +3.92% | -0.46% | -5.56% | -51.70% | 209B | |
| +1.80% | +2.30% | +11.56% | +66.16% | 165B | |
| Average | +1.02% | +0.94% | +33.76% | +43.87% | 402.31B | |
| Weighted average by Cap. | +0.66% | +1.33% | +48.72% | +63.85% |
Employees
-
Sector
Pharmaceuticals
